- A true walk away ‘sample to answer’ molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories
- Utilizes Seegene’s patented, cutting-edge high multiplex real-time PCR technologies to provide ‘Real’ Ct values of individual pathogens in a single channel.
- Incorporates Seegene’s broad menu of molecular diagnostics for syndromic testing, for detection of SARS-CoV-2 and variants.
SEOUL, South Korea, Oct. 28, 2021 /PRNewswire/ — South Korea’s leading molecular diagnostics (MDx) developer Seegene Inc., (KQ 096530) is addressing the needs of small, mid-sized, and large hospitals and COVID-19 laboratories with its fully automated STARlet-AIOS: All-in-One System (AIOS). First unveiled at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo in Atlanta, the modular system supports a “hands-free” PCR workflow, automating everything from nucleic acid extraction to the interpretation of results. This can help sites boost their testing capacity while lessening the burden on laboratory and hospital staff.
“Seegene has played a critical role in the global response to the COVID-19 pandemic, in large part because of our forward-looking strategy. We moved fast from day one, rapidly developing a reliable assay for the novel coronavirus and then pivoting to multiplexed tests that can detect emerging SARS-CoV-2 variants,” said Dr. Jong-Yoon Chun, Seegene Founder and CEO. “As we look ahead, the most pressing diagnostic need will be for cost-effective and high throughput automated systems that can remove any remaining testing bottlenecks. Our all-in-one system specifically addresses that need for hospitals and laboratories of all sizes.”
More than 3.75 billion people worldwide have now received at least one dose of a COVID-19 vaccine. As daily case counts and fatalities decline, many countries are easing their restrictions and preparing to live with the virus. Doing so safely will require ongoing surveillance, with accurate PCR testing and rapid turnaround times.
The modular design of STARlet-AIOS: All-in-One System unites two standalone instruments––the STARlet IVD and the CFX96™ Dx real-time PCR System––with a custom-built robotic arm. This unique engineering allows customers to either purchase the full AIOS system or integrate existing Seegene instruments already in use. With its compact and intuitive design, the AIOS is accessible to small-to-medium sized hospitals and clinics, along with larger organizations.
Seegene’s current portfolio with an extensive test menu including GI, HPV, STI, respiratory assays as well as a suite of SARS-CoV-2 assays detecting a wide range of variants (namely, Alpha, Beta, Gamma, Delta, Epsilon, kappa, Lambda, Mu, etc.) can all be processed using the AIOS. The system will also be compatible with newly developed assays and Seegene’s MOBILE STATION, an innovative laboratory-on-wheels initiative that delivers mass testing capacity to communities that would otherwise lack the necessary infrastructure.
Meanwhile, the company plans to introduce Allplex™ Respiratory Virus Master Assay, in late 2021, a single tube syndromic assay that can differentiate between COVID-19 and other major common respiratory pathogens, such as influenza, RSV, adenovirus, parainfluenza, metapneumovirus, human rhinovirus. The introduction of the new assay will help doctors treat cases more effectively, by differentiating causative pathogens of COVID-19 and respiratory viruses for common flu, which may surge in winter season.
Jetex announces its first FBO in London, a top-tier destination for the brand’s robust international expansion Dubai, United Arab Emirates, May 20, 2022 (GLOBE NEWSWIRE) — London is a natural next destination for Jetex, an award-winning global leader in executive aviation, and it becomes the brand’s 35th international FBO location. Jetex entered in an agreement […]
TORONTO, 19 mai 2022 (GLOBE NEWSWIRE) — Advance Local, l’un des plus grands groupes de médias aux États-Unis exploitant 10 organisations d’information et d’actualités de premier plan et touchant 55 millions de personnes chaque mois, a quadruplé son objectif d’abonnement en utilisant Sophi Content Paywall Engine. Face aux pressions publicitaires exacerbées par le coronavirus, Advance Local a […]
TORONTO, May 19, 2022 (GLOBE NEWSWIRE) — A Advance Local, um dos maiores grupos de mídia dos Estados Unidos que opera 10 principais organizações de notícias e informações e atinge 55 milhões de pessoas por mês, quadruplicou sua meta de assinatura com o Sophi Content Paywall Engine. Diante das pressões publicitárias intensificadas pelo Coronavírus, a […]
Gro Intelligence launches the first publicly available interactive tool on key agricultural commodities for 49 African countries NEW YORK, May 19, 2022 /PRNewswire/ — During the United Nations Security Council’s session on Conflict and Global Food Security, Gro Intelligence’s CEO, Sara Menker, spoke about the growing global food crisis, its disproportionate impact on lower-income countries, […]
Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product range Rijswijk, The Netherlands, May 19, 2022 (GLOBE NEWSWIRE) — Summary Centrient Pharmaceuticals reached a significant milestone in the clean production of its antibiotics, with the lowest environmental impact and minimizing the potential contribution to antimicrobial resistance The company […]
Collaboration on open data and technology to bolster maritime surveillance in West Africa London, United Kingdom, May 18, 2022 (GLOBE NEWSWIRE) — LONDON, May 19, 2022 – A new partnership agreement between Benin and Global Fishing Watch aims to strengthen monitoring, control and surveillance of fishing activities within the waters of the West African State. […]